BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31356526)

  • 1. Differentiation of Hepatic Sclerosed Hemangiomas From Cavernous Hemangiomas Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features.
    Hwang JA; Kang TW; Cha DI; Kim SH; Ha SY; Kim SW
    J Comput Assist Tomogr; 2019; 43(5):762-769. PubMed ID: 31356526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA.
    Vernuccio F; Bruno A; Costanzo V; Bartolotta TV; Vieni S; Midiri M; Salvaggio G; Brancatelli G
    Curr Probl Diagn Radiol; 2020; 49(6):398-403. PubMed ID: 31253462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
    Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
    AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of qualitative and quantitative imaging features of hepatic hemangiomas with and without pseudo-washout sign on gadoxetic acid-enhanced MRI: a descriptive and comparative study.
    Aslan S; Onder RO; Sulun E; Taşdemir MN
    Acta Radiol; 2024 Jan; 65(1):23-32. PubMed ID: 37264586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study.
    Jia C; Liu G; Wang X; Zhao D; Li R; Li H
    Jpn J Radiol; 2021 Nov; 39(11):1059-1068. PubMed ID: 34041675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
    Nam SJ; Yu JS; Cho ES; Kim JH; Chung JJ
    Clin Radiol; 2017 Mar; 72(3):247-254. PubMed ID: 27789027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerosed hemangioma of the liver: concordance of MRI features with histologic characteristics.
    Ridge CA; Shia J; Gerst SR; Do RK
    J Magn Reson Imaging; 2014 Apr; 39(4):812-8. PubMed ID: 24783239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Shiratori Y; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2010 Oct; 195(4):941-6. PubMed ID: 20858822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating primary hepatic angiosarcomas from hemangiomatosis and epithelioid hemangioendotheliomas using gadoxetic acid-enhanced and diffusion-weighted MR imaging.
    Seo JW; Kim SH; Kim AY; Jeong WK; Woo JY; Park WJ
    Jpn J Radiol; 2017 Nov; 35(11):655-663. PubMed ID: 28879422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating malignant from benign hyperintense nodules on unenhanced T1-weighted images in patients with chronic liver disease: using gadoxetic acid-enhanced and diffusion-weighted MR imaging.
    Moon JY; Kim SH; Choi SY; Hwang JA; Lee JE; Lee J
    Jpn J Radiol; 2018 Aug; 36(8):489-499. PubMed ID: 29876721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns.
    Leslie DF; Johnson CD; Johnson CM; Ilstrup DM; Harmsen WS
    AJR Am J Roentgenol; 1995 Mar; 164(3):625-9. PubMed ID: 7863883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Sclerosed Hemangioma: a case report and review of the literature.
    Miyamoto S; Oshita A; Daimaru Y; Sasaki M; Ohdan H; Nakamitsu A
    BMC Surg; 2015 Apr; 15():45. PubMed ID: 25927893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid.
    Ahn SJ; Kim MJ; Hong HS; Kim KA; Song HT
    J Magn Reson Imaging; 2011 Aug; 34(2):310-7. PubMed ID: 21598345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypically enhanced cavernous hemangiomas of the liver: centrifugal enhancement does not preclude the diagnosis of hepatic hemangioma.
    Matsushita M; Takehara Y; Nasu H; Hirai Y; Yamashita S; Souda K; Kobayashi Y; Miura K
    J Gastroenterol; 2006 Dec; 41(12):1227-30. PubMed ID: 17287903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Hemangiomas: Factors Associated with Pseudo Washout Sign on Gd-EOB-DTPA-enhanced MR Imaging.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Nakamura F
    Magn Reson Med Sci; 2016; 15(1):73-82. PubMed ID: 26346400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change.
    Choi J; Yu JS; Cho ES; Kim JH; Chung JJ
    Radiol Med; 2018 May; 123(5):323-330. PubMed ID: 29357040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating Liver Hemangioma from Metastatic Tumor Using T2-enhanced Spin-echo Imaging with a Time-reversed Gradient-echo Sequence in the Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging.
    Takayama Y; Nishie A; Okamoto D; Fujita N; Asayama Y; Ushijima Y; Yoshizumi T; Yoneyama M; Ishigami K
    Magn Reson Med Sci; 2022 Jul; 21(3):445-457. PubMed ID: 33883364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
    Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
    Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
    Soyer P; Dufresne AC; Somveille E; Scherrer A
    AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging findings of primary hepatic angiosarcoma on gadoxetate disodium-enhanced liver MRI: comparison with hepatic haemangiomas of similar size.
    Kim B; Byun JH; Lee JH; Park BJ; Kwon HJ; Lee JH; Lee SJ; Won HJ; Shin YM; Kim PN
    Clin Radiol; 2018 Mar; 73(3):244-253. PubMed ID: 29111237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.